Home › Funds › LUMINUS MANAGEMENT LLC › VTGN
LUMINUS MANAGEMENT LLC position in VTGN
VISTAGEN THERAPEUTICS INC · Health Care
LUMINUS MANAGEMENT LLC reported holding 403,115 shares of VTGN (VISTAGEN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$91K, representing 0.06% of its reported portfolio and ranking #29 among its reported holdings. LUMINUS MANAGEMENT LLC has disclosed VTGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How LUMINUS MANAGEMENT LLC's VTGN position evolved
LUMINUS MANAGEMENT LLC first disclosed a stake in VTGN in Q4 2025 at 350,000 shares (US$232K). Across 3 filings, LUMINUS MANAGEMENT LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 403,115 shares valued at US$91K — an increase of 7,062 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 350.00K | $231.66K | New |
| Q1 2026 | 396.05K | $226.34K | Add |
| Q2 2026 | 403.12K | $91.10K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VTGN and 13F data
VTGN (VISTAGEN THERAPEUTICS INC) is a Health Care company. 8 other funds we track also report a position in VTGN — the largest reported positions include Commodore Capital LP (US$630K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on LUMINUS MANAGEMENT LLC
FAQ
How long has LUMINUS MANAGEMENT LLC held VTGN?
LUMINUS MANAGEMENT LLC has disclosed VTGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is LUMINUS MANAGEMENT LLC's current position in VTGN?
As of Q2 2026, LUMINUS MANAGEMENT LLC holds 403.12K shares of VTGN (VISTAGEN THERAPEUTICS INC), valued at $91.10K, representing 0.06% of its reported portfolio and ranking #29.
Has LUMINUS MANAGEMENT LLC been buying or selling VTGN?
In the latest 13F filing (Q2 2026), LUMINUS MANAGEMENT LLC increased its position in VTGN.
Which other funds hold VTGN?
Other major institutional holders of VTGN include Commodore Capital LP, among 8 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.